- Exchange: NYSE MKT LLC
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Actinium Pharmaceuticals Inc+ Add to Watchlist
ATNM:US6.2900 USD 0.0500 0.79%
As of 20:04:02 ET on 08/27/2014.
Company Profile for Actinium Pharmaceuticals Inc (ATNM)
Actinium Pharmaceuticals Inc. operates as a biopharmaceutical company. The Company develops alpha particle immunotherapeutics and other radiopharmaceuticals for select applications.
Actinium Pharmaceuticals Inc
Key Executives for Actinium Pharmaceuticals Inc (ATNM)
|Kaushik J DavePresident/CEO/Interim CFO||Dragan CicicCOO/Chief Medical Officer|